Brief: Clearside Biomedical To Report Oasis Phase 1/2A Clinical Trial Results And Host Conference Call On Wednesday, November 9, 2022 In Conjunction With Third Quarter 2022 Financial Results
08/11/2022 23:03
Nov 8 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL TO REPORT OASIS PHASE 1/2A CLINICAL
TRIAL
RESULTS AND HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 9, 2022
IN CONJUNCTION WITH THIRD QUARTER 2022 FINANCIAL RESULTS
Source text for Eikon: ID:nGNXbSzCfd
Further company coverage: CLSD.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials